Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex.
about
NeuroAIDS, drug abuse, and inflammation: building collaborative research activitiesA prospective longitudinal in vivo 1H MR spectroscopy study of the SIV/macaque model of neuroAIDSNeuroimaging biomarkers of neurodegenerative diseases and dementiaLower cognitive reserve in the aging human immunodeficiency virus-infected brain.Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain.Alcoholism and AIDS: magnetic resonance imaging approaches for detecting interactive neuropathology.Changes in cerebral metabolism are detected prior to perfusion changes in early HIV-CMC: A coregistered (1)H MRS and SPECT study.Cerebral MR spectroscopy in neurologically asymptomatic HIV-infected patients.In vivo proton magnetic resonance spectroscopy reveals region specific metabolic responses to SIV infection in the macaque brain.Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementiaProton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDSBrain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individualsNeuropsychological aspects of coinfection with HIV and hepatitis C virus.Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS.HIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS ProjectLower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorderCerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infectionEstrogen: effects on normal brain function and neuropsychiatric disorders.Longitudinal cerebral metabolic changes in pig-tailed macaques infected with the neurovirulent virus SIVsmmFGb.The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infectionsAbnormal MEG oscillatory activity during visual processing in the prefrontal cortices and frontal eye-fields of the aging HIV brain.Neurometabolite abnormalities in simian immunodeficiency virus-infected macaques with chronic morphine administrationHippocampal MR spectroscopic abnormalities in a cohort of syphilitic patients with HIV and neurosyphilis infection.Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatmentBrain creatine elevation and N-Acetylaspartate reduction indicates neuronal dysfunction in the setting of enhanced glial energy metabolism in a macaque model of neuroAIDSExploring the relationship of macrophage colony-stimulating factor levels on neuroaxonal metabolism and cognition during chronic human immunodeficiency virus infection.3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometryCD8+ lymphocyte depletion without SIV infection does not produce metabolic changes or pathological abnormalities in the rhesus macaque brain.A comparison of two post-processing analysis methods to quantify cerebral metabolites measured via proton magnetic resonance spectroscopy in HIV diseaseCerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.2D MR Spectroscopy Combined with Prior-Knowledge Fitting Is Sensitive to HCV-Associated Cerebral Metabolic Abnormalities.Study to assess the prevalence, nature and extent of cognitive impairment in people living with AIDS.Absence of Cerebrospinal Fluid Signs of Neuronal Injury Before and After Immediate Antiretroviral Therapy in Acute HIV Infection.Hepatitis C virus infection, and neurological and psychiatric disorders - A review.Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction.Whole brain diffusion tensor imaging in HIV-associated cognitive impairmentDifferences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts.Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: neurocognitive and neuroimaging featuresNeuroinflammation in treated HIV-positive individuals: A TSPO PET study.Factor analysis reveals differences in brain metabolism in macaques with SIV/AIDS and those with SIV-induced encephalitis.
P2860
Q23915009-7CCA4A5F-88CB-4C4E-907B-F92C542EE0A5Q24803530-49B11395-EE73-42C4-9598-1C8E8A7BC07EQ27691820-808D166E-6A94-41B8-BF8C-8D8F1C338835Q30440212-0626B941-FE09-4B05-A4E3-80A26F507032Q30624704-70F6C2D5-F672-477F-B0F9-0696B11B9D84Q30712330-B6B0CD5A-11D4-4A9B-BFB3-49AFFE1E6798Q31651608-699AD8BA-C444-4DFD-B4A9-4170E75267BAQ33186698-B4A4837B-4263-40A5-BF9B-43D01362CAEEQ33471824-3E406923-13F7-4DD7-BAFE-FB8902733958Q33525781-21B50B7F-E399-4CC6-8C00-869F9DEDB7D4Q33580220-B7F59FEC-4E4C-42D7-A288-97B22AA21DA7Q33614467-188E7229-F333-4B29-86B2-FB1924FCEE44Q33888133-FDB823B4-F961-4E15-879B-50A4A56F9722Q33919945-843AD52D-5654-44F9-8DE3-22D76513C32DQ34076133-FE57176C-16C2-450B-B60F-752B2EC8062AQ34257820-887C705A-5C68-4AE7-88A0-07BDBBA7FA1DQ34466521-D662FD7D-78A2-4FB4-A44C-9D3D2BBE735BQ34583150-F3E53C97-3DF5-4E47-A42F-874ED1CB0CC4Q34714799-1780CFF3-D417-4A08-A9FA-8931E779B46AQ34787585-DA150549-64D8-40BE-9A69-344510FEAF8EQ34805196-68461375-08FF-481A-BE45-463CECB1D5CCQ34883734-93283CF1-004A-45C0-A476-02A1312D3C8BQ34987714-3BA8AF3C-BEC6-46A0-A73B-818C4F80A16AQ35078313-75E956BB-08FE-4B96-9449-C82D57CE513AQ35116137-EFEA4E70-7344-4F76-B3BE-2435D22FA95DQ35189591-5A9BC617-EA84-4990-B5BA-14FA22F9B9ACQ35401301-3404BB4A-9FAA-49AA-AC83-120C78EC0D2AQ35738499-3F316924-7362-4A4B-9EFA-190D1880CAACQ35949256-3E875DF6-6CA9-4919-B20B-D1FB428275D1Q36028974-22AA9776-7BD1-4D50-B0E2-3E6931D8D312Q36111496-0EDE7DAD-EBC2-49CC-9DD8-E396E6F5F56AQ36231152-4EA615A6-0724-46E0-8979-5EB696B4DA2DQ36250205-2C1620EB-52C7-4E58-961F-59E356087588Q36266948-474B1B34-9748-496D-9F48-4F1B8C8238D4Q36420372-92EA3109-A482-484F-910B-EF267CF3797AQ36511545-BFEF56F1-6ADB-4FAF-8069-061CCA5638B9Q36589672-7D41BB2B-4737-4BF9-9BBB-8BA41CD45485Q36792636-9BC270DD-D283-4A3B-88B4-C0FED9C14BEFQ36796466-583D941F-3FC4-47F8-8507-DD697F30CACAQ36924984-2B16DEFE-EEEB-4838-A8EE-699A144BE993
P2860
Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Cerebral metabolite abnormalit ...... HIV-1 cognitive motor complex.
@en
Cerebral metabolite abnormalit ...... HIV-1 cognitive motor complex.
@nl
type
label
Cerebral metabolite abnormalit ...... HIV-1 cognitive motor complex.
@en
Cerebral metabolite abnormalit ...... HIV-1 cognitive motor complex.
@nl
prefLabel
Cerebral metabolite abnormalit ...... HIV-1 cognitive motor complex.
@en
Cerebral metabolite abnormalit ...... HIV-1 cognitive motor complex.
@nl
P2093
P356
P1433
P1476
Cerebral metabolite abnormalit ...... HIV-1 cognitive motor complex.
@en
P2093
P304
P356
10.1212/WNL.52.1.100
P407
P577
1999-01-01T00:00:00Z